Latest Breaking News On - Priya singhal - Page 1 : comparemela.com

Biogen Immunology Strategy Comes Into Focus With $1B HI-Bio Acquisition

Biogen Immunology Strategy Comes Into Focus With $1B HI-Bio Acquisition
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

Priya singhalWilliam blairMyles minterReata pharmaceuticalsEuropean renal association congressVertex pharmaceuticalsAlpine immune sciencesHuman immunology biosciencesChinook therapeuticsSan francisco bay area

Longwood Healthcare Leaders Spring MIT to Convene Life Science Thought Leaders at MIT Koch Institute

BOSTON, MA / ACCESSWIRE / May 23, 2024 / Longwood Fund, an early-stage life science venture firm, will convene top biopharmaceutical leaders for two days of discussion and networking at its annual Longwood

Dana farber cancer instituteUnited statesJake auchinclossSally kornbluthArielle jacksonPeter marksBrian goffStephen hogeLaurie glimcherDeborah dunsireAnne klibanskiChristophe weberAl sandrockMikael dolstenRochelle walenskyChris viehbacher

Longwood Healthcare Leaders Spring MIT to Convene Life Science Thought

Longwood Healthcare Leaders Spring MIT to Convene Life Science Thought
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

Dana farber cancer instituteUnited statesChris viehbacherJake auchinclossMathai mammenPeter marksAl sandrockRochelle walenskyBob langerArielle jacksondirectorSally kornbluthChristophe weberDeborah dunsireBrian goffMikael dolstenAnne klibanski

Biogen Buys Biotech Firm HI-Bio to Boost Its Immunology Portfolio

Biogen has agreed to pay at least $1.15 billion for biotech firm Human Immunology Biosciences as it moves to increase its immunology portfolio.

Priya singhalHead of development at biogenHuman immunology biosciences

Biogen to expand immunology and rare disease portfolio with $1 8bn HI-Bio acquisition

Biogen to expand immunology and rare disease portfolio with $1 8bn HI-Bio acquisition
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Priya singhalReata pharmaceuticalsDrug administrationBiogen idecHuman immunology biosciencesSan francisco bay areaBreakthrough therapy designationOrphan drug designation